Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Tracking error arises from fees, sampling, and/index composition differences. This intro covers primary causes and practical mitigation ideas.
19,096 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Palantir's quarterly results spotlight more than top-line growth. The real signal is how much existing customers are ...
A bold investment in a brain health biotech signals conviction in early-stage science. This article breaks down what ...
Symbotic's shiny narrative has investors buzzing, but the biggest gains often hinge on real execution, not just optim...
Can Netflix grow from its current scale to a trillion-dollar market value? This article breaks down the unlikely path...
After a sharp drop in Robinhood stock, investors wonder what comes next. This article breaks down scenarios, real-wor...
Turning 65 triggers Medicare decisions that can impact your budget for decades. This guide explains what every high-i...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
The pandemic reshaped Americans' trust in science and altered how households save, spend, and invest. This report out...
Nuclear energy is attracting new attention from investors. This guide compares NuScale Power and Constellation Energy...
A quartet of high-yield international ETFs has posted stronger returns than the S&P 500 over the past year, deliverin...